Halma expands capabilities in advanced healthcare assessment with acquisition of PeriGen, Inc.

27 April 2021

Halma, the global group of life-saving technology companies, has acquired PeriGen, Inc., ("PeriGen"), based in North Carolina, US.

PeriGen is highly aligned to Halma's purpose of growing a safer, cleaner, healthier future for everyone, every day. Its advanced perinatal technology protects mothers and their unborn babies by alerting doctors, midwives and nurses to potential problems during childbirth.

The software solution uses artificial intelligence to provide an automated early warning platform during labour, enabling healthcare professionals to assess complex data more easily and allowing them to spend more time on direct patient care.

PeriGen's technology and market presence will complement Halma's existing Medical sector technologies. It broadens Halma's market presence in advanced patient assessment and monitoring, and further extends Halma's capabilities in artificial intelligence and analytics.

PeriGen will be managed as a standalone company and will become part of Halma's Medical sector.

Andrew Williams, Group Chief Executive of Halma, said:

"We are excited by the opportunities offered by PeriGen's digital technology in helping clinicians protect the health of mothers and babies during childbirth, while achieving better clinical outcomes in the increasing proportion of complex births. PeriGen is highly aligned with our purpose, broadens our presence in patient assessment and monitoring into the US perinatal care market, and further extends our artificial intelligence and analytics capabilities."